Wang HF - Search Results

1

Venetoclax for arsenic-resistant acute promyelocytic leukaemia.

Wang QQ, Wang HF, Zhao JZ, Naranmandura H, Jin J, Zhu HH. Wang QQ, et al. Among authors: wang hf. Br J Haematol. 2022 Jun;197(5):e58-e60. doi: 10.1111/bjh.18061. Epub 2022 Feb 17. Br J Haematol. 2022. PMID: 35176809 No abstract available.

2

Trisomy 21 in patients with acute leukemia.

Cheng Y, Wang H, Wang H, Chen Z, Jin J. Cheng Y, et al. Am J Hematol. 2009 Mar;84(3):193-4. doi: 10.1002/ajh.21339. Am J Hematol. 2009. PMID: 19140190 Free article. No abstract available.

3

CD19-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired karyotypic abnormality.

Wang HF, Cheng YZ, Wang HP, Chen ZM, Lou JY, Jin J. Wang HF, et al. Among authors: wang hp. J Zhejiang Univ Sci B. 2009 Nov;10(11):833-8. doi: 10.1631/jzus.B0820362. J Zhejiang Univ Sci B. 2009. PMID: 19882758 Free PMC article.

4

Novel influenza A (H1N1) in patients with hematologic disease.

Wei JY, Chen FF, Jin J, Mai WY, Qian WB, Meng HT, Mao LP, Xu GX, Wang HF, Lou YJ, Tong HY. Wei JY, et al. Among authors: wang hf. Leuk Lymphoma. 2010 Nov;51(11):2079-83. doi: 10.3109/10428194.2010.508823. Leuk Lymphoma. 2010. PMID: 21077745

5

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial.

Jin J, Wang JX, Chen FF, Wu DP, Hu J, Zhou JF, Hu JD, Wang JM, Li JY, Huang XJ, Ma J, Ji CY, Xu XP, Yu K, Ren HY, Zhou YH, Tong Y, Lou YJ, Ni WM, Tong HY, Wang HF, Mi YC, Du X, Chen BA, Shen Y, Chen Z, Chen SJ. Jin J, et al. Among authors: wang jx, wang hf, wang jm. Lancet Oncol. 2013 Jun;14(7):599-608. doi: 10.1016/S1470-2045(13)70152-9. Epub 2013 May 9. Lancet Oncol. 2013. PMID: 23664707 Clinical Trial.

6

Clonal chromosomal abnormalities in Philadelphia-negative cells in chronic myeloid leukemia patients treated with nilotinib used in first-line therapy.

Wang H, Jin J, Wang Y, Huang X, Huang J. Wang H, et al. Ann Hematol. 2013 Dec;92(12):1625-32. doi: 10.1007/s00277-013-1816-z. Epub 2013 Jun 23. Ann Hematol. 2013. PMID: 23793947

7

The combination effect of homoharringtonine and ibrutinib on FLT3-ITD mutant acute myeloid leukemia.

Li X, Yin X, Wang H, Huang J, Yu M, Ma Z, Li C, Zhou Y, Yan X, Huang S, Jin J. Li X, et al. Oncotarget. 2017 Feb 21;8(8):12764-12774. doi: 10.18632/oncotarget.14463. Oncotarget. 2017. PMID: 28061447 Free PMC article.

8

[Clinical features and prognosis of acute myeloid leukemia with acquired trisomy 21].

Lu Y, Yuan J, Wang H, Pei R, Chen Z, Jin J. Lu Y, et al. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Aug 10;34(4):554-558. doi: 10.3760/cma.j.issn.1003-9406.2017.04.019. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017. PMID: 28777858 Chinese.

9

Primary central nervous system lymphoma: Retrospective analysis of 34 cases in a single centre.

Wang H, Wang M, Wei J, Wang L, Mao L, Jin J. Wang H, et al. J Int Med Res. 2018 Feb;46(2):883-894. doi: 10.1177/0300060517734395. Epub 2017 Oct 6. J Int Med Res. 2018. PMID: 28984175 Free PMC article.

10

Outcome of adult T-lymphoblastic lymphoma depends on ALL-type chemotherapy, prognostic factors, and performance of allogeneic hematopoietic stem cell transplantation.

Hu M, Wang H, Wang L, Yang M, Lou Y, Jin J. Hu M, et al. Medicine (Baltimore). 2018 Jul;97(28):e11374. doi: 10.1097/MD.0000000000011374. Medicine (Baltimore). 2018. PMID: 29995776 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,488 results

Search Page